AUTERRA INC. – Trademark Portfolio

Entity Type: 03

AUTERRA INC. has 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 4 Nice Classification classes, led by Class 1 (Chemicals) and Class 42 (Computer & Scientific). This trademark owner is based in Schenectady, NY.

2135 Technology Drive

Schenectady, NY 12308

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FLEXULS
FLEXULS
Abandoned 2022
PHOSFIRE
PHOSFIRE
Cancelled 2015
FLEXUP
FLEXUP
Cancelled 2015
FLEXDS
FLEXDS
Abandoned 2015
FLEXDS
FLEXDS
Abandoned 2013
FLEXUP
FLEXUP
Cancelled 2013
FLEXOX
FLEXOX
Cancelled 2013
AUTERRA
AUTERRA
Cancelled 2011
FLEX DS
FLEX DS
Abandoned 2011

Trademark Classifications

AUTERRA INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

37
Building & Construction (2 filings)

Building construction; repair; installation services

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does AUTERRA INC. have?

AUTERRA INC. has 9 U.S. trademarks filed with the USPTO.

What trademark classes does AUTERRA INC. file in?

AUTERRA INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 37 (Building & Construction), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is AUTERRA INC.'s trademark registration success rate?

AUTERRA INC. has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.